A review on potential of PARP inhibitors in the treatment of prostate cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Hlavní autor: | Islam, Saidul |
|---|---|
| Další autoři: | Sharmin, Shahana |
| Médium: | Diplomová práce |
| Jazyk: | English |
| Vydáno: |
Brac University
2022
|
| Témata: | |
| On-line přístup: | http://hdl.handle.net/10361/17308 |
Podobné jednotky
-
A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Autor: Karim, Azrin
Vydáno: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Autor: Flora, Sanzida Alam
Vydáno: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Autor: Meem, Manila
Vydáno: (2023) -
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Autor: Alam, Tahera
Vydáno: (2024) -
RIPK pathway, as a potential target, for cancer treatment - a review
Autor: Jahan, Nusrat
Vydáno: (2024)